Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 291

1.

The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF).

Sackeim HA, Aaronson ST, Bunker MT, Conway CR, Demitrack MA, George MS, Prudic J, Thase ME, Rush AJ.

J Psychiatr Res. 2019 Jun;113:125-136. doi: 10.1016/j.jpsychires.2019.03.021. Epub 2019 Mar 22. Review.

2.

Simple Electroencephalographic Treatment-Emergent Marker Can Predict Repetitive Transcranial Magnetic Stimulation Antidepressant Response-A Feasibility Study.

Isserles M, Daskalakis ZJ, George MS, Blumberger DM, Sackeim HA, Shahaf G.

J ECT. 2018 Dec;34(4):274-282. doi: 10.1097/YCT.0000000000000551.

PMID:
30407932
3.

Modern Electroconvulsive Therapy: Vastly Improved yet Greatly Underused.

Sackeim HA.

JAMA Psychiatry. 2017 Aug 1;74(8):779-780. doi: 10.1001/jamapsychiatry.2017.1670. No abstract available.

PMID:
28658461
4.

Defining Treatment-Resistant Depression-Reply.

Conway CR, George MS, Sackeim HA.

JAMA Psychiatry. 2017 Jul 1;74(7):759. doi: 10.1001/jamapsychiatry.2017.0970. No abstract available.

PMID:
28564688
5.

Response to Hoy, 'Gender Imbalance at Brain Stimulation Conferences: We Have a Problem and It is Everyone's Problem'.

George MS, Sackeim HA.

Brain Stimul. 2017 Jan - Feb;10(1):157. doi: 10.1016/j.brs.2016.10.011. Epub 2016 Nov 1. No abstract available.

PMID:
28007474
6.

Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression: When Enough Is Enough.

Conway CR, George MS, Sackeim HA.

JAMA Psychiatry. 2017 Jan 1;74(1):9-10. doi: 10.1001/jamapsychiatry.2016.2586. No abstract available.

PMID:
27784055
7.

Expanded Safety and Efficacy Data for a New Method of Performing Electroconvulsive Therapy: Focal Electrically Administered Seizure Therapy.

Sahlem GL, Short EB, Kerns S, Snipes J, DeVries W, Fox JB, Burns C, Schmidt M, Nahas ZH, George MS, Sackeim HA.

J ECT. 2016 Sep;32(3):197-203. doi: 10.1097/YCT.0000000000000328.

8.

Acute Continuation and Maintenance Treatment of Major Depressive Episodes With Transcranial Magnetic Stimulation.

Sackeim HA.

Brain Stimul. 2016 May-Jun;9(3):313-319. doi: 10.1016/j.brs.2016.03.006. Epub 2016 Mar 11. No abstract available.

PMID:
27052475
9.

Is the Seizure an Unnecessary Component of Electroconvulsive Therapy? A Startling Possibility.

Sackeim HA.

Brain Stimul. 2015 Sep-Oct;8(5):851-4. doi: 10.1016/j.brs.2015.07.026. Epub 2015 Jul 17. No abstract available.

PMID:
26358486
10.

A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.

Dunner DL, Aaronson ST, Sackeim HA, Janicak PG, Carpenter LL, Boyadjis T, Brock DG, Bonneh-Barkay D, Cook IA, Lanocha K, Solvason HB, Demitrack MA.

J Clin Psychiatry. 2014 Dec;75(12):1394-401. doi: 10.4088/JCP.13m08977.

11.

Regional cerebral blood flow changes associated with focal electrically administered seizure therapy (FEAST).

Chahine G, Short B, Spicer K, Schmidt M, Burns C, Atoui M, George MS, Sackeim HA, Nahas Z.

Brain Stimul. 2014 May-Jun;7(3):483-5. doi: 10.1016/j.brs.2014.02.011. Epub 2014 Feb 22.

PMID:
24795198
12.

Autobiographical memory and electroconvulsive therapy: do not throw out the baby.

Sackeim HA.

J ECT. 2014 Sep;30(3):177-86. doi: 10.1097/YCT.0000000000000117.

13.

Antidepressant treatment of melancholia in older adults.

Sneed JR, Reinlieb ME, Rutherford BR, Miyazaki M, Fitzsimons L, Turret N, Pelton GH, Devanand DP, Sackeim HA, Roose SP.

Am J Geriatr Psychiatry. 2014 Jan;22(1):46-52. doi: 10.1016/j.jagp.2013.02.001. Epub 2013 Oct 8.

PMID:
24119858
14.

The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS Trial.

Borckardt JJ, Nahas ZH, Teal J, Lisanby SH, McDonald WM, Avery D, Durkalski V, Pavlicova M, Long JM, Sackeim HA, George MS.

Brain Stimul. 2013 Nov;6(6):925-8. doi: 10.1016/j.brs.2013.04.009. Epub 2013 May 21.

15.

A feasibility study of a new method for electrically producing seizures in man: focal electrically administered seizure therapy [FEAST].

Nahas Z, Short B, Burns C, Archer M, Schmidt M, Prudic J, Nobler MS, Devanand DP, Fitzsimons L, Lisanby SH, Payne N, Perera T, George MS, Sackeim HA.

Brain Stimul. 2013 May;6(3):403-8. doi: 10.1016/j.brs.2013.03.004. Epub 2013 Mar 16.

PMID:
23518262
16.

In memoriam--Vahe E. Amassian.

Cracco RQ, Rothwell JC, Sackeim HA, George MS.

Brain Stimul. 2013 Mar;6(2):99-100. doi: 10.1016/j.brs.2013.01.012. Epub 2013 Feb 15. No abstract available.

PMID:
23498287
17.

Role of hippocampal neurogenesis in mnemonic segregation: implications for human mood disorders.

Perera TD, Thirumangalakudi L, Glennon E, Park S, Insanally M, Persky M, Fonseka J, Dwork AJ, Sackeim HA, Coplan JD, Fenton AA.

World J Biol Psychiatry. 2013 Dec;14(8):602-10. doi: 10.3109/15622975.2013.768356. Epub 2013 Feb 11.

PMID:
23398296
18.

Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.

Prudic J, Haskett RF, McCall WV, Isenberg K, Cooper T, Rosenquist PB, Mulsant BH, Sackeim HA.

J ECT. 2013 Mar;29(1):3-12. doi: 10.1097/YCT.0b013e31826ea8c4.

19.

Poor health-related quality of life prior to ECT in depressed patients normalizes with sustained remission after ECT.

McCall WV, Reboussin D, Prudic J, Haskett RF, Isenberg K, Olfson M, Rosenquist PB, Sackeim HA.

J Affect Disord. 2013 May;147(1-3):107-11. doi: 10.1016/j.jad.2012.10.018. Epub 2012 Nov 15.

20.

Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.

Mantovani A, Pavlicova M, Avery D, Nahas Z, McDonald WM, Wajdik CD, Holtzheimer PE 3rd, George MS, Sackeim HA, Lisanby SH.

Depress Anxiety. 2012 Oct;29(10):883-90. doi: 10.1002/da.21967. Epub 2012 Jun 11.

21.

Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trial.

Johnson KA, Baig M, Ramsey D, Lisanby SH, Avery D, McDonald WM, Li X, Bernhardt ER, Haynor DR, Holtzheimer PE 3rd, Sackeim HA, George MS, Nahas Z.

Brain Stimul. 2013 Mar;6(2):108-17. doi: 10.1016/j.brs.2012.02.003. Epub 2012 Mar 14.

22.

Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression.

McDonald WM, Durkalski V, Ball ER, Holtzheimer PE, Pavlicova M, Lisanby SH, Avery D, Anderson BS, Nahas Z, Zarkowski P, Sackeim HA, George MS.

Depress Anxiety. 2011 Nov;28(11):973-80. doi: 10.1002/da.20885. Epub 2011 Sep 2.

23.

A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease.

Devanand DP, Pelton GH, Cunqueiro K, Sackeim HA, Marder K.

Int J Geriatr Psychiatry. 2011 Sep;26(9):937-43. doi: 10.1002/gps.2630. Epub 2010 Dec 28.

24.

Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates.

Perera TD, Dwork AJ, Keegan KA, Thirumangalakudi L, Lipira CM, Joyce N, Lange C, Higley JD, Rosoklija G, Hen R, Sackeim HA, Coplan JD.

PLoS One. 2011 Apr 15;6(4):e17600. doi: 10.1371/journal.pone.0017600.

25.

Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.

McCall WV, Rosenquist PB, Kimball J, Haskett R, Isenberg K, Prudic J, Lasater B, Sackeim HA.

J ECT. 2011 Jun;27(2):97-102. doi: 10.1097/YCT.0b013e318205c7d7.

PMID:
21206285
26.

Self-evaluation of the cognitive effects of electroconvulsive therapy.

Brakemeier EL, Berman R, Prudic J, Zwillenberg K, Sackeim HA.

J ECT. 2011 Mar;27(1):59-66. doi: 10.1097/YCT.0b013e3181d77656.

PMID:
20926956
27.

Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.

George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, Anderson B, Nahas Z, Bulow P, Zarkowski P, Holtzheimer PE 3rd, Schwartz T, Sackeim HA.

Arch Gen Psychiatry. 2010 May;67(5):507-16. doi: 10.1001/archgenpsychiatry.2010.46.

PMID:
20439832
28.

Electroconvulsive therapy in treatment-resistant schizophrenia: prediction of response and the nature of symptomatic improvement.

Chanpattana W, Sackeim HA.

J ECT. 2010 Dec;26(4):289-98. doi: 10.1097/YCT.0b013e3181cb5e0f.

PMID:
20375701
29.

Decreasing procedural pain over time of left prefrontal rTMS for depression: initial results from the open-label phase of a multi-site trial (OPT-TMS).

Anderson BS, Kavanagh K, Borckardt JJ, Nahas ZH, Kose S, Lisanby SH, McDonald WM, Avery D, Sackeim HA, George MS.

Brain Stimul. 2009 Apr;2(2):88-92. doi: 10.1016/j.brs.2008.09.001.

30.

Reply regarding "efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial".

O'Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, McDonald WM, Avery D, Fitzgerald PB, Loo C, Demitrack MA, George MS, Sackeim HA.

Biol Psychiatry. 2010 Jan 15;67(2):e15-7. doi: 10.1016/j.biopsych.2009.06.027. No abstract available.

PMID:
19914602
31.

Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects.

Sackeim HA, Dillingham EM, Prudic J, Cooper T, McCall WV, Rosenquist P, Isenberg K, Garcia K, Mulsant BH, Haskett RF.

Arch Gen Psychiatry. 2009 Jul;66(7):729-37. doi: 10.1001/archgenpsychiatry.2009.75.

PMID:
19581564
32.

Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy.

Fallon BA, Lipkin RB, Corbera KM, Yu S, Nobler MS, Keilp JG, Petkova E, Lisanby SH, Moeller JR, Slavov I, Van Heertum R, Mensh BD, Sackeim HA.

Arch Gen Psychiatry. 2009 May;66(5):554-63. doi: 10.1001/archgenpsychiatry.2009.29.

PMID:
19414715
33.

Focal electrically administered therapy: device parameter effects on stimulus perception in humans.

Borckardt JJ, Linder KJ, Ricci R, Li X, Anderson B, Arana A, Nahas Z, Amassian V, Long J, George MS, Sackeim HA.

J ECT. 2009 Jun;25(2):91-8. doi: 10.1097/YCT.0b013e318183c6a4.

34.

Brain stimulation, revolutions, and the shifting time domain of depression.

George MS, Sackeim HA.

Biol Psychiatry. 2008 Sep 15;64(6):447-8. doi: 10.1016/j.biopsych.2008.07.013. No abstract available.

35.

Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial.

Lisanby SH, Husain MM, Rosenquist PB, Maixner D, Gutierrez R, Krystal A, Gilmer W, Marangell LB, Aaronson S, Daskalakis ZJ, Canterbury R, Richelson E, Sackeim HA, George MS.

Neuropsychopharmacology. 2009 Jan;34(2):522-34. doi: 10.1038/npp.2008.118. Epub 2008 Aug 13.

36.

Neurobiological correlates of the cognitive side effects of electroconvulsive therapy.

Nobler MS, Sackeim HA.

J ECT. 2008 Mar;24(1):40-5. doi: 10.1097/YCT.0b013e31815d6957. Review.

PMID:
18379334
37.

Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy.

Sackeim HA, Prudic J, Nobler MS, Fitzsimons L, Lisanby SH, Payne N, Berman RM, Brakemeier EL, Perera T, Devanand DP.

Brain Stimul. 2008 Apr;1(2):71-83. doi: 10.1016/j.brs.2008.03.001. Erratum in: Brain Stimul. 2008 Jul;1(3):A2.

38.

It is time to take a stand for medical research and against terrorism targeting medical scientists.

Krystal JH, Carter CS, Geschwind D, Manji HK, March JS, Nestler EJ, Zubieta JK, Charney DS, Goldman D, Gur RE, Lieberman JA, Roy-Byrne P, Rubinow DR, Anderson SA, Barondes S, Berman KF, Blair J, Braff DL, Brown ES, Calabrese JR, Carlezon WA Jr, Cook EH Jr, Davidson RJ, Davis M, Desimone R, Drevets WC, Duman RS, Essock SM, Faraone SV, Freedman R, Friston KJ, Gelernter J, Geller B, Gill M, Gould E, Grace AA, Grillon C, Gueorguieva R, Hariri AR, Innis RB, Jones EG, Kleinman JE, Koob GF, Krystal AD, Leibenluft E, Levinson DF, Levitt PR, Lewis DA, Liberzon I, Lipska BK, Marder SR, Markou A, Mason GF, McDougle CJ, McEwen BS, McMahon FJ, Meaney MJ, Meltzer HY, Merikangas KR, Meyer-Lindenberg A, Mirnics K, Monteggia LM, Neumeister A, O'Brien CP, Owen MJ, Pine DS, Rapoport JL, Rauch SL, Robbins TW, Rosenbaum JF, Rosenberg DR, Ross CA, Rush AJ, Sackeim HA, Sanacora G, Schatzberg AF, Shaham Y, Siever LJ, Sunderland T, Tecott LH, Thase ME, Todd RD, Weissman MM, Yehuda R, Yoshikawa T, Young EA, McCandless R.

Biol Psychiatry. 2008 Apr 15;63(8):725-7. doi: 10.1016/j.biopsych.2008.03.005. No abstract available. Erratum in: Biol Psychiatry. 2008 May 15;63(10):1001.

PMID:
18371494
39.

Subjective evaluation of the therapeutic and cognitive effects of electroconvulsive therapy.

Berman RM, Prudic J, Brakemeier EL, Olfson M, Sackeim HA.

Brain Stimul. 2008 Jan;1(1):16-26. doi: 10.1016/j.brs.2007.08.005. Epub 2007 Dec 3.

PMID:
20633366
40.

Brain stimulation-basic, translational, and clinical research in neuromodulation: Why a new journal?

Sackeim HA, George MS.

Brain Stimul. 2008 Jan;1(1):4-6. doi: 10.1016/j.brs.2007.09.002. Epub 2007 Dec 3. No abstract available.

PMID:
20633365
41.

Focal electrical stimulation as a sham control for repetitive transcranial magnetic stimulation: Does it truly mimic the cutaneous sensation and pain of active prefrontal repetitive transcranial magnetic stimulation?

Arana AB, Borckardt JJ, Ricci R, Anderson B, Li X, Linder KJ, Long J, Sackeim HA, George MS.

Brain Stimul. 2008 Jan;1(1):44-51. doi: 10.1016/j.brs.2007.08.006.

42.

Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.

Pelton GH, Harper OL, Tabert MH, Sackeim HA, Scarmeas N, Roose SP, Devanand DP.

Int J Geriatr Psychiatry. 2008 Jul;23(7):670-6.

43.

Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression.

Sneed JR, Rutherford BR, Rindskopf D, Lane DT, Sackeim HA, Roose SP.

Am J Geriatr Psychiatry. 2008 Jan;16(1):65-73. Epub 2007 Nov 12. Review.

PMID:
17998306
44.

A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy.

Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, Dwyer E, Slavov I, Cheng J, Dobkin J, Nelson DR, Sackeim HA.

Neurology. 2008 Mar 25;70(13):992-1003. Epub 2007 Oct 10.

PMID:
17928580
45.

Response inhibition predicts poor antidepressant treatment response in very old depressed patients.

Sneed JR, Roose SP, Keilp JG, Krishnan KR, Alexopoulos GS, Sackeim HA.

Am J Geriatr Psychiatry. 2007 Jul;15(7):553-63.

PMID:
17586780
46.

Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.

O'Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, McDonald WM, Avery D, Fitzgerald PB, Loo C, Demitrack MA, George MS, Sackeim HA.

Biol Psychiatry. 2007 Dec 1;62(11):1208-16. Epub 2007 Jun 14.

PMID:
17573044
47.

Response to Drs Abrams and Kellner: the cognitive effects of ECT in community settings.

Sackeim HA, Prudic J, Olfson M.

J ECT. 2007 Jun;23(2):65-7. No abstract available.

PMID:
17548970
48.

Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.

Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B.

Arch Gen Psychiatry. 2007 Jun;64(6):679-88.

PMID:
17548749
49.

Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates.

Perera TD, Coplan JD, Lisanby SH, Lipira CM, Arif M, Carpio C, Spitzer G, Santarelli L, Scharf B, Hen R, Rosoklija G, Sackeim HA, Dwork AJ.

J Neurosci. 2007 May 2;27(18):4894-901.

50.

Acceptability of second-step treatments to depressed outpatients: a STAR*D report.

Wisniewski SR, Fava M, Trivedi MH, Thase ME, Warden D, Niederehe G, Friedman ES, Biggs MM, Sackeim HA, Shores-Wilson K, McGrath PJ, Lavori PW, Miyahara S, Rush AJ.

Am J Psychiatry. 2007 May;164(5):753-60.

PMID:
17475734

Supplemental Content

Loading ...
Support Center